Home > Products > E

Featured China E Products

  • efavirenz  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    AFINE CHEMICALS LIMITED    
  • Efavirenz  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    Zhejiang Shaxing Technology Co.,Ltd.    
  • Efavirenz  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    AFINE CHEMICALS LIMITED    
  • Efavirenz  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    SUNWELL CHEMICALS CO.,LTD.    
  • Efavirenz  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    Daming Changda Co.,Ltd.    
  • Efavirenz  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    Hangzhou Pharma & Chem Co.,Ltd.    
  • EFAVIRENZ  154598-52-4

    ;(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1... >>>

    JAI RADHE SALES    

Total 6652 Products,Showing 47 / 666|‹   ‹‹   41 42 43 44 45 46 47 48 49 50 ›› ›|

Our other sites: ChinaChemNet - ChemNet - ChemNetCAS - PharmNet - ChinaTexNet - Toocle - Sunsirs - TexIndex - China Medical Device - Trading Services

© 1997- ChinaChemNet.com Corporation and its licensors. All rights reserved.